225 related articles for article (PubMed ID: 1550399)
1. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.
Brand CA; Rowley MJ; Tait BD; Muirden KD; Whittingham SF
Ann Rheum Dis; 1992 Feb; 51(2):173-6. PubMed ID: 1550399
[TBL] [Abstract][Full Text] [Related]
2. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis in Greece: clinical, serological and genetic considerations.
Drosos AA; Moutsopoulos HM
Clin Exp Rheumatol; 1995; 13 Suppl 12():S7-12. PubMed ID: 8846545
[TBL] [Abstract][Full Text] [Related]
4. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus.
Gunnarsson I; Kanerud L; Pettersson E; Lundberg I; Lindblad S; Ringertz B
Br J Rheumatol; 1997 Oct; 36(10):1089-94. PubMed ID: 9374926
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis.
Boire G; Ménard HA
J Rheumatol; 1988 Mar; 15(3):391-4. PubMed ID: 3259983
[TBL] [Abstract][Full Text] [Related]
6. U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies.
Dugan EM; Tunnessen WW; Honig PJ; Watson RM
Arch Dermatol; 1992 Nov; 128(11):1490-4. PubMed ID: 1444503
[TBL] [Abstract][Full Text] [Related]
7. Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.
Bell DA; Maddison PJ
Arthritis Rheum; 1980 Nov; 23(11):1268-73. PubMed ID: 6969593
[TBL] [Abstract][Full Text] [Related]
8. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease.
Harley JB; Sestak AL; Willis LG; Fu SM; Hansen JA; Reichlin M
Arthritis Rheum; 1989 Jul; 32(7):826-36. PubMed ID: 2787639
[TBL] [Abstract][Full Text] [Related]
9. Clinical, serological and immunogenetic features of Japanese anti-Ro/SS-A-positive patients with annular erythema.
Miyagawa S
Dermatology; 1994; 189 Suppl 1():11-3. PubMed ID: 8049546
[TBL] [Abstract][Full Text] [Related]
10. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
11. Distribution of an anti-DNA idiotype among autoantibodies in patients with systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA).
Harkiss GD; Hendrie F; Nuki G
J Clin Immunol; 1986 Jul; 6(4):292-8. PubMed ID: 3489001
[TBL] [Abstract][Full Text] [Related]
12. No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.
Yao Z; Hartung K; Ehrfeld H; Seelig HP; Deicher HG; Brünnler G; Keller E; Albert E
Rheumatol Int; 1993; 13(4):155-8. PubMed ID: 8310208
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster.
Boire G; Ménard HA; Gendron M; Lussier A; Myhal D
J Rheumatol; 1993 Oct; 20(10):1654-60. PubMed ID: 8295174
[TBL] [Abstract][Full Text] [Related]
14. Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients: role of TAP2*01 alleles in Ro autoantibody production.
Martín-Villa JM; Martínez-Laso J; Moreno-Pelayo MA; Castro-Panete MJ; Martínez-Quiles N; Alvarez M; de Juan MD; Gómez-Reino JJ; Arnaiz-Villena A
Ann Rheum Dis; 1998 Apr; 57(4):214-9. PubMed ID: 9709177
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients.
Savi M; Ferraccioli GF; Neri TM; Zanelli P; Dall'Aglio PP; Tincani A; Balestrieri G; Carella G; Cattaneo R
Arthritis Rheum; 1988 Dec; 31(12):1568-70. PubMed ID: 3196369
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets.
Hochberg MC; Boyd RE; Ahearn JM; Arnett FC; Bias WB; Provost TT; Stevens MB
Medicine (Baltimore); 1985 Sep; 64(5):285-95. PubMed ID: 2412088
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR antigens in Blacks with rheumatoid arthritis and systemic lupus erythematosus.
Alarif LI; Ruppert GB; Wilson R; Barth WF
J Rheumatol; 1983 Apr; 10(2):297-300. PubMed ID: 6602882
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetics of systemic lupus erythematosus in Spanish patients: differential HLA markers.
Gómez-Reino JJ; Martínez-Laso J; Vicario JL; Paz-Artal E; Aragón A; Martín-Villa JM; De Juan MD; Pérez-Aciego P; Arnaiz-Villena A
Immunobiology; 1991 Aug; 182(5):465-71. PubMed ID: 1916886
[TBL] [Abstract][Full Text] [Related]
20. Anti La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus.
Maddison PJ; Isenberg DA; Goulding NJ; Leddy J; Skinner RP
Br J Rheumatol; 1988 Feb; 27(1):27-31. PubMed ID: 3257399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
